MedTrace Logo

Evaluation of a Nutraceutical for Endometriosis Pain Relief

NCT04091191 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2023-03-16

No results posted yet for this study

Summary

Based on the EHP-30 questionnaire, the pain score and general well-being of all patients will be assessed with and without taking a specialized nutraceutical. These patients will be taking continuous oral contraception, for 3 months before inclusion till at least end of the study or not taking any oral contraception at all during the study due to contraindication(s).

Conditions

  • Endometriosis

Interventions

DIETARY_SUPPLEMENT

Meta19.01

A specialized nutraceutical containing plant extracts, vitamins and fish oil

Sponsors & Collaborators

  • Metagenics Europe

    lead INDUSTRY

Principal Investigators

  • Yaacoub Salame, MD · CHU Ambroise Paré de Mons

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-13
Primary Completion
2022-12-16
Completion
2022-12-16

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04091191 on ClinicalTrials.gov